首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Concise syntheses and HCV NS5B polymerase inhibition of (2′ R )-3 and (2′ S )-2′-ethynyluridine-10 and related nucleosides
【24h】

Concise syntheses and HCV NS5B polymerase inhibition of (2′ R )-3 and (2′ S )-2′-ethynyluridine-10 and related nucleosides

机译:简洁的合成和HCV NS5B聚合酶抑制(2'R)-3和(2's)-2'-乙炔酰脲-10和相关核苷的抑制作用

获取原文
获取原文并翻译 | 示例
           

摘要

Graphical abstract Display Omitted Abstract (2′ R )-Ethynyl uridine 3 , and its (2′ S )-diastereomer 10 , are synthesised in a divergent fashion from the inexpensive parent nucleoside. Both nucleoside analogues are obtained from a total of 5 simple synthetic steps and 3 trivial column chromatography purifications. To evaluate their effectiveness against HCV NS5B polymerase, the nucleosides were converted to their respective 5′-O-triphosphates. Subsequently, this lead to the discovery of the 2′-β-ethynyl 18 and -propynyl 20 nucleotides having significantly improved potency over Sofosbuvir triphosphate 24 .
机译:图形摘要显示省略摘要(2'R) - 乙炔尿苷3,其(2's)-DiaSteROMer 10以廉价的母体核苷以发散方式合成。 核苷类似物的总共可获得5个简单的合成步骤和3个普通柱色谱纯化。 为了评估它们对HCV NS5B聚合酶的有效性,将核苷转化为它们各自的5'-O-三磷酸。 随后,这导致2'-β-乙炔基18和-20丙炔基的发现,其具有显着改善的辛磷吡咯三磷酸24的效力显着改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号